S1493 The Impact of Mirikizumab Induction, Maintenance, and Long-Term Treatment on Disease Clearance in Patients With Moderately to Severely Active Ulcerative Colitis: Post-Hoc Analysis of LUCENT Trials
Year: 2024
Type: conference-abstract
Institutions: Icahn School of Medicine at Mount Sinai, Kitasato Institute Hospital, Kitasato University, Eli Lilly (United States), Western University, Eli Lilly (Portugal), Dartmouth–Hitchcock Medical Center, Humboldt-Universität zu Berlin, Freie Universität Berlin, Charité – Universitätsmedizin Berlin, Hospital de São João
Language: English
Topic: Inflammatory Bowel Disease
Subfield: Gastroenterology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4403722804